🇺🇸 FDA
Patent

US 9115094

Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using

granted A61KA61K49/106A61P

Quick answer

US patent 9115094 (Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using) held by The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS) expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS)
Grant date
Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K49/106, A61P, A61P25/16, A61P25/28